(Q39956327)

15 September 2017

title

Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma (English)

1 reference

15 September 2017

2

1 reference

15 September 2017

6

1 reference

15 September 2017

10

Richard Gorlick

1 reference

15 September 2017

5

Tanasa S Osborne

1 reference

15 September 2017

Ayesha Abdeen

1

1 reference

15 September 2017

John H Healey

3

1 reference

15 September 2017

Chand Khanna

4

1 reference

15 September 2017

Mimi Kim

7

1 reference

15 September 2017

Dan Wang

8

1 reference

15 September 2017

Karen Moody

9

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

115

1 reference

15 September 2017

issue

22

1 reference

15 September 2017

page(s)

5243-5250

1 reference

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group

15 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.24562

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.24562

Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis

21 January 2018

1 reference

12 December 2020

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

12 December 2020

Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement

1 reference

12 December 2020

Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma

1 reference

12 December 2020

A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy.

1 reference

12 December 2020

A system for the surgical staging of musculoskeletal sarcoma

1 reference

12 December 2020

VEGF expression in osteosarcoma correlates with vascular permeability by dynamic MRI

2 references

12 December 2020

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.24562

7 January 2021

inferred from DOI database lookup

Osteogenic sarcoma with clinically detectable metastasis at initial presentation

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.24562

1 reference

15 September 2017

0 references

1 reference